Will u consider last result announcement of HGH as downgrade ? As it came below market expectations same as revenue guidance of FPH came below market expectations but not below FPH guidance as they never gave any ...so I will not consider FPH revenue guidance as out of blue " Downgrade " ...it was very much expected after 80+ % overshoot of previous year .
Will I be expecting more bad news in the short term ...very possible till they get that bearing or new base year ...which as already predicted is 2023 ...
All analysts had these numbers forecasted long ago ...path to normalisation after big overshoot was spread over 2-3 years .All already on the horizon .
Yes SP reaction got exaggerated by current market situation of rates / inflation and war etc ...so it went 10-15% below expected lines ...otherwise 50 million less on 1750 consensus is hardly downgrade ...next year 1650 can surely become 1550 ...but 2022 eps consensus of 66 cents and of 2023 of 59 cents will hold or be exceeded most likely ....I will wait for results to see that ...missing earnings by 3-5 % is not that important for FPH in the longer term picture . Also they never guided anything so they are not downgrading anything ...just gave revenue guidance after knowing 11 months figures ...which due to Omicron's mildness resulted in less severe hospitalisations needing respiratory support ...which can change either way ahead but most likely it will keep resolving to become better so dependence on covid hospitalisations ahead will keep becoming less and less .
Original business which had revenues of 1.2 Billion in 2020 will take main stream as normalisation of revenues and earnings will happen . Forecasts and over deliverance will start ...hopefully from 2024 . I can wait till that ...will market keep SP depressed till that is a big question to which all know answer .